华神科技(000790.SZ):拟以自有资金在海南省投设全资子公司
格隆汇 1 月 19日丨华神科技(000790.SZ)公布,为构建中医药大健康产业链战略布局,培育新的利润增长点,公司拟以自有资金在海南省投资设立全资子公司,注册资本5000万元。
此次投资是公司抓住中医药大健康行业发展机遇,经过深入研究后的战略布局,有利于公司完善医药产业结构,构建华神大健康产业链,进一步提高公司的综合竞争能力和盈利能力。有利于公司加大与国内外知名药企的深度合作,以创新发展的理念加速推动中医中药走出国门。有利于公司借助政策优势引进各类专业人才,为公司在新的领域和现代中药领域的长期发展提供多方位的支持。有助于公司借助海南建设自贸区的政策优势,把握医药大健康产业快速发展带来的市场机遇,促进中医健康产业深度融合发展,为公司整体战略目标的实现和持续、长远的发展发挥积极作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.